Free Trial

Global X Aging Population ETF Rating

$32.14 +0.21 (+0.66%)
Closing price 03:47 PM Eastern
Extended Trading
$32.14 0.00 (0.00%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Global X Aging Population ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

AGNG Aggregate Rating

Moderate Buy
2.69

Holdings in AGNG have an aggregate rating of Moderate Buy based on 539 analyst ratings issued in the past year covering 31 companies (56.5% of the portfolio).

AGNG Aggregate Price Target

$32.14
High Prediction$32.14
Average Prediction$32.14
Low Prediction$32.14

Holdings in AGNG have an aggregate price target of $32.14 and a range of $32.14 to $32.14 covering 31 companies (56.5% of the portfolio).

AGNG Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
Moderate Buy
17 Moderate Buy rating(s)
Hold
10 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Global X Aging Population ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 31 AGNG Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
3.06%
Welltower Inc. stock logo
WELL
Welltower
$157.53
+0.5%
4.6856 of 5 stars
2.92$168.18 6.8%12Positive News
3.05%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$103.12
-0.4%
4.613 of 5 stars
3.13$116.09 12.6%24Upcoming Earnings
3.02%
Stryker Corporation stock logo
SYK
Stryker
$390.65
+0.0%
4.4447 of 5 stars
2.79$428.55 9.7%19Positive News
Analyst Forecast
3.01%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$76.15
-0.9%
4.3568 of 5 stars
2.48$81.00 6.4%27Positive News
Upcoming Earnings
Analyst Forecast
2.98%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$70.08
-0.3%
3.7225 of 5 stars
2.83$89.00 27.0%6Trending News
Analyst Revision
2.95%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$788.91
+2.2%
4.9753 of 5 stars
2.75$1,012.56 28.3%20Trending News
Analyst Revision
2.88%
AbbVie Inc. stock logo
ABBV
AbbVie
$190.53
+2.2%
4.7786 of 5 stars
2.81$211.29 10.9%27Trending News
Analyst Revision
2.86%
Medtronic PLC stock logo
MDT
Medtronic
$89.74
+0.6%
4.4623 of 5 stars
2.59$98.19 9.4%22Positive News
Analyst Forecast
Analyst Revision
2.82%
Amgen Inc. stock logo
AMGN
Amgen
$299.02
+2.2%
4.3973 of 5 stars
2.35$307.82 2.9%23Trending News
Analyst Revision
2.74%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$164.78
+6.2%
4.7716 of 5 stars
2.55$171.00 3.8%20Trending News
Earnings Report
Dividend Announcement
Options Volume
Gap Up
High Trading Volume
2.74%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$82.45
+1.1%
4.9978 of 5 stars
2.43$108.69 31.8%21Positive News
2.53%
DexCom, Inc. stock logo
DXCM
DexCom
$84.13
-0.8%
4.7821 of 5 stars
2.91$99.60 18.4%22Positive News
Analyst Forecast
2.51%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$547.93
0.0%
4.8047 of 5 stars
2.80$814.57 48.7%25
2.41%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$47.16
+1.6%
4.8945 of 5 stars
2.32$57.69 22.3%22Analyst Revision
2.18%
Ventas, Inc. stock logo
VTR
Ventas
$65.49
+0.5%
4.4166 of 5 stars
3.00$72.90 11.3%12Insider Trade
1.99%
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$279.16
+3.5%
2.4948 of 5 stars
3.00$324.89 16.4%7Analyst Forecast
1.69%
Insulet Corporation stock logo
PODD
Insulet
$288.27
-0.6%
4.5651 of 5 stars
2.83$321.00 11.4%18Positive News
Analyst Revision
1.43%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$94.20
+0.2%
4.9499 of 5 stars
2.35$111.39 18.3%20News Coverage
Analyst Upgrade
1.05%
Incyte Corporation stock logo
INCY
Incyte
$69.23
+1.4%
4.6752 of 5 stars
2.22$74.47 7.6%18Trending News
Analyst Forecast
Insider Trade
Analyst Revision
1.04%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$298.16
+1.7%
4.9865 of 5 stars
2.69$383.08 28.5%13Positive News
Insider Trade
1.00%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$133.48
+1.7%
4.4935 of 5 stars
2.87$163.91 22.8%23Trending News
Analyst Revision
0.90%
Exelixis, Inc. stock logo
EXEL
Exelixis
$44.81
+1.7%
4.7568 of 5 stars
2.52$45.28 1.0%21Analyst Forecast
0.86%
DaVita Inc. stock logo
DVA
DaVita
$140.23
-0.2%
4.4184 of 5 stars
2.00$164.50 17.3%6Positive News
0.83%
Omega Healthcare Investors, Inc. stock logo
OHI
Omega Healthcare Investors
$37.96
-0.1%
4.0963 of 5 stars
2.44$42.25 11.3%9Positive News
Analyst Upgrade
0.77%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$53.67
+1.3%
4.6736 of 5 stars
2.95$70.50 31.4%22
0.71%
The Ensign Group, Inc. stock logo
ENSG
The Ensign Group
$139.85
-0.9%
4.9244 of 5 stars
2.83$163.50 16.9%6Positive News
0.65%
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
$129.28
-0.1%
1.0941 of 5 stars
2.24$128.25 -0.8%21Positive News
High Trading Volume
0.52%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$58.01
+2.5%
4.8376 of 5 stars
2.17$62.70 8.1%12Positive News
Analyst Forecast
0.46%
Glaukos Corporation stock logo
GKOS
Glaukos
$98.51
+0.3%
4.3346 of 5 stars
2.75$134.67 36.7%12Analyst Forecast
0.45%
CG Oncology, Inc. stock logo
CGON
CG Oncology
$26.08
+4.5%
2.7577 of 5 stars
3.08$55.30 112.0%12News Coverage
Positive News
Analyst Forecast
0.44%
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
$22.55
+2.5%
4.1007 of 5 stars
2.71$27.88 23.6%17Analyst Revision

This page (NASDAQ:AGNG) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners